CRM Directional Report
Analysis based on market close March 31, 2026
Outlook
Neutral-to-bearish with a gravitational pull toward $190-$195 max pain levels. Confidence: 7.5/10. The regime is dominated by negative GEX (trending) and mixed flow, suggesting volatility and potential downside pressure, but the proximity to max pain provides a short-term magnet.
Conflicts: Mixed flow regime (P/C vol 1.07, P/C OI 0.86) and rising max pain trend ($190→$195) suggest underlying bullish gravity.
Regime Classification
Price Range Forecast
Key Levels
Dealer Positioning (GEX/DEX)
GEX: $-13.5M
DEX: +20.5M shares
Gamma flip: N/A
NTM gamma: No specific gamma flip level provided. With **negative GEX**, dealer hedging will **add to momentum** in the direction of spot moves (buy on rallies, sell on dips). A move ±2% from here accelerates dealer activity, increasing volatility.
IV Analysis
IV vs VIX: IV 46% is rich — favorable for premium sellers, but the negative GEX regime increases the risk of large moves.
Term structure: **Steeply upward sloping** from 33.9% (2d) to 48.4% (38d), then settles ~43%. **Key kink at 5/8 expiry (48.4%)**, likely pricing an event (possibly earnings anticipation).
Skew: **5/8 expiry (38 DTE) IV is 48.4% vs. 5/15 (45 DTE) at 40.6% — a ~8 vol-point differential.** This supports a reverse calendar spread (sell rich 5/8, buy cheaper 5/15).
Flow Analysis
Net premium: **Net premium -$35.3M bearish**; P/C vol 1.07 (balanced), P/C OI 0.86 (slight call bias in positioning).
Directional prints: **1) $180P 5/15: Vol 34,261 vs OI 3,570 (9.6x).** Could be bought puts for protection or sold puts for income; bearish premium flow at $180 supports bought interpretation. **2) $190C 5/15: Vol 25,946 vs OI 776 (33.4x).** Likely bought calls given high volume/OI ratio and bullish premium flow at $190. **Structural flow summary:** Massive bearish premium at deep OTM strikes ($180, $250, $260, $330) suggests institutional put buying for tail-risk hedging.
Unusual: $172.50C 4/17 with IV 50.1% — far OTM call with elevated vol, could be a speculative long or part of a complex spread.
Risks & Catalysts
Strategy Viability
| Strategy | Edge | Best Setup | Primary Risk |
|---|---|---|---|
| Long Stock | Moderate-Weak | N/A | Negative GEX and bearish net premium flow provide headwinds; better to wait for a test of the $182.74 support. |
| Short Stock | Moderate | N/A | Negative GEX supports trending downside, but max pain pin and rising MP trend create strong counter-trend gravity near $190. |
| Covered Call | Moderate-Strong | Own stock, sell the $195C 4/17 (above max pain, near weekly EM high). | Stock rallies past $195, shares called away; negative GEX could fuel a faster move up. |
| Cash-Secured Put / Put Spread | Moderate-Strong | Sell $180/$175 put spread 5/15 (below support, collects rich 45 DTE vol). | Break below $175 EM support; negative GEX accelerates losses. |
| Long Calls | Moderate-Weak | Buy $190C 4/10 (targeting max pain pin). | IV is rich (37%), and negative GEX can cause whipsaw; pin may not materialize. |
| Long Puts / Bear Put Spread | Moderate | Buy $185P / Sell $180P 4/17 bear put spread (betting on failure to hold max pain). | Max pain pin to $190 causes time decay; IV crush on range-bound action. |
| Iron Condor | Weak | $182.5P/$177.5P x $195C/$200C 4/17 (within EM bounds). | Negative GEX regime strongly disfavors range-bound strategies; high risk of a break outside wings. |
| Calendar/Diagonal | Moderate-Strong | **Reverse Calendar:** Sell $190C 5/8 (48.4% IV), Buy $190C 5/15 (40.6% IV). Benefits from vol differential decay. | Directional move away from $190 hurts; pin at $190 maximizes theta/vol harvest. |
| PMCC / LEAPS Diagonal | Moderate | Buy $190C Jan 2027 (43.3% IV), Sell $195C 4/17 or 5/8 against it. | Capital intensive; near-term pin failure and negative GEX can pressure short leg. |
Top Plays
Watchlist Triggers
Tactical Summary
Read the Directional analysis for CRM for 2026-03-31. This AI-generated report covers regime classification, key price levels, strategy recommendations, and actionable trade ideas drawn from end-of-day options data including gamma exposure, delta exposure, and implied volatility.